Clinical Hematology Research Career Development Program (K12)
The summary for the Clinical Hematology Research Career Development Program (K12) Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
| Federal Grant Title: | CLINICAL HEMATOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM (K12) |
| Federal Agency Name: | National Institutes of Health |
| Program Name: | Blood Diseases and Resources Research |
| Grant Categories: | Health |
| CFDA Number: | 93.839 |
| Funding Opportunity Number: | RFA-HL-06-006 |
| Posted Date: | Dec 05, 2005 |
| Creation Date: | Dec 05, 2005 |
| Original Application Deadline: | Feb 14, 2006 |
| Current Application Deadline: | Information not provided |
| Archive Date: | Mar 16, 2006 |
| Total Program Funding: | $2,000,000 |
| Maximum Federal Grant Award: | $370,000 |
| Minimum Federal Grant Award: | Information not provided |
| Expected Number of Awards: | 5 |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Although foreign institutions are not eligible to apply, foreign collaborators may participate in this program through subcontract(s) with domestic institutions. Applicant institutions must have established clinical research infrastructures and expertise in non-malignant clinical hematology, and strong clinical research faculty with expertise in the related disciplines. . See Section III.3.Other-Specialty Eligibility Criteria.
- Grant Description
- Purpose: The purpose of this Program is to develop and evaluate multidisciplinary career development programs in non-malignant hematology that will equip new investigators with the knowledge and skills to address complex problems in blood diseases. Through this Program, the NHLBI will support the early career development of clinical researchers who are expected to become independent investigators and assume academic leadership roles in non-malignant clinical hematology. To accomplish this, NHLBI invites institutions with established clinical research infrastructures and expertise in non-malignant clinical hematology to submit applications to establish Clinical Hematology Research Career Development Programs. Programs supported under this RFA should provide comprehensive, multidisciplinary training in research designs and methodologies, standard and potentially future or innovative approaches to the clinical management of patients with non-malignant hem! atologic diseases, and research opportunities in these diseases. Programs should include a core curriculum, didactics, and a short-term research project for each Scholar.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-06-006.html http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-06-006.html
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Erythropoiesis: Components and Mechanisms (R01)
- • Selected Topics in Transfusion Medicine (R01)
- • Selected Topics in Transfusion Medicine (R21)
- • Trans-Agency Research Consortium for Trauma-Induced Coagulopathy (TACTIC) (UM1)
- • Excellence in Hemoglobinopathies Research Award (EHRA) (U54)
- • Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
- • Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
- • Specialized Centers of Clinically Oriented Research (Sccor) in Transfusion Biology and Med...
- More Grants from the National Institutes of Health
- • Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral...
- • Research on the Role of Epigenetics in Social, Behavioral, Environmental and Biological Re...
- • Pediatric Critical Care and Trauma Scientist Development Program (K12)
- • Evidence-based Demonstration Projects in Immunization (Admin Supp)
- • Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the...